Oventus

Oventus

Oventus

Oventus has developed the O2Vent, a custom-made oral device that is assisting patients by stopping or significantly reducing snoring.
Type
B2c
Raised
$6.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$6,500,000
Post-IPO equity - 2017
Team Size
1–10
Employees
Location
Headquarters
$6,500,000 Post-IPO equity
MassDevice

Sleep apnea dev Oventus Medical raises $6m

ZDNet

ASX-listed Oventus Medical opens 3D printing facility with CSIRO

Manufacturing Materials Health
ZDNet

​Oventus to use AU$12m ASX debut to commercialise 3D-printed mouthguard

Health Materials